Catherine Madigan

Insider Reports History

Entity
Individual
Location
35 Gatehouse Drive, Building D, Floor 3, Waltham, MA
Signature
/s/ Michael A. Metzger, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Catherine Madigan:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Syndax Pharmaceuticals Inc Chief Medical Officer Stock Options (Right to buy) 110K $2.84M $25.84 Feb 2, 2023 Direct

Insider Reports Filed by Catherine Madigan

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SNDX Syndax Pharmaceuticals Inc Feb 2, 2023 1 $3.14M 4 Feb 3, 2023 Chief Medical Officer
SNDX Syndax Pharmaceuticals Inc Mar 1, 2022 1 $2.89M 4 Mar 3, 2022 Chief Medical Officer
SNDX Syndax Pharmaceuticals Inc Mar 1, 2022 0 $0 3 Mar 3, 2022 Chief Medical Officer